SDAC: Clinical Trials Brown Bag Discussion Series
| Title | Date | Presenter |
|---|---|---|
| The FDA’s Final Rule on Expedited Safety Reporting: Implications for Data Monitoring of Clinical Trials | Wednesday, October 5, 2016 – 12:00pm to 1:00pm | Robin Bechhofer |
| OSLER: An Open-Label Randomized Extension Trial of Evolocumab | Wednesday, October 7, 2015 – 12:00pm | Marian Fisher |
| Electroconvulsive Therapy for Severe Depression | Wednesday, September 9, 2015 – 12:00pm | Neil Baron |
| Conducting Valid Trials: the Critical (and Misunderstood) Roles of Randomization and Complete Follow-Up | Wednesday, May 6, 2015 – 12:00pm to 1:00pm | Tom Cook — a preview of the workshop to be presented at SCT 2015 |
| Clinical Trial Research in the Context of a Global Epidemic: Drug and Vaccine Studies for Ebola Virus Disease | Wednesday, March 4, 2015 – 12:00pm to 1:00pm | Robin Bechhofer |
| Transparency, Sharing, and Reanalysis of Clinical Trial Data: Recent Publications | Wednesday, February 4, 2015 – 12:00pm to 1:00pm | Melissa Schultz |
| Social Media and Crowdsourcing: A Consideration of Impacts on Clinical Trials and Health Research | Wednesday, January 7, 2015 – 12:00pm to 1:00pm | Allison Furey |
| A Review of Analyses for Drug Induced Liver Injury | Wednesday, December 17, 2014 – 12:00pm to 1:00pm | Gabriel Nicholas |
| STABILITY/SOLID TIMI-52 Darapladib Trials: Background, Results, and Monitoring | Wednesday, November 12, 2014 – 12:00pm to 1:00pm | Scott Diegel |
| Mindfulness Meditation as an Intervention for Chronic Low Back Pain | Wednesday, October 8, 2014 – 12:00pm to 1:00pm | John Kloke |
| Temporal Changes in Post-Discharge Risk among Patients Hospitalized for Heart Failure: An EVEREST Story | Wednesday, September 3, 2014 – 12:00pm to 1:00pm | Ryan Zea Abstract: Studies have shown patients suffering from a heart failure hospitalization are at higher risk for an adverse event in the first 90 days post-discharge. This claim has led to the conclusion of a vulnerable phase for these patients. The vulnerable phase hypothesis has ties to research, health care, and quality of care initiatives. However, as the case with chronic diseases, shouldn’t risk continue to increase over time? A post-hoc analysis of the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) trial, may show just that. |
| The Study of Platelet Inhibition and Patient Outcomes (PLATO) Trial: Criticism and Responses | Wednesday, May 14, 2014 – 12:00pm to 1:00pm | Brian Traver |
| Fish Oil: Benefits of Omega-3 Polyunsaturated Fatty Acids | Wednesday, April 2, 2014 – 12:00pm to 1:00pm | Neil Baron |
| Everolimus: A mTOR Inhibitor for Treatment of Breast Cancer | Wednesday, February 5, 2014 – 12:00pm to 1:00pm | Weiqun Tong |
| Adaptive Trials from 30,000 Feet | Wednesday, January 8, 2014 – 12:00pm to 1:00pm | Tom Cook |
| 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: Context and Controversy | Wednesday, December 4, 2013 – 12:00pm to 1:00pm | Marian Fisher |
| PKCS-9 Monoclonal Antibodies for Treatment of High LDL-Cholesterol | Wednesday, November 6, 2013 – 12:00pm to 1:00pm | Kevin Buhr |
| Issues from the FDA Advisory Committee Meeting to Review the New Drug Application (NDA) for the use of Tovaptan to Treat Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Wednesday, October 2, 2013 – 12:00pm to 1:00pm | Robin Bechhofer |
| Studies from the SDAC Archives: PROMISE and PRAISE | Wednesday, May 1, 2013 – 12:00pm to 1:00pm | Jan Feyzi |
| The Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF) Trial: Overview and Results | Wednesday, April 3, 2013 – 12:00pm to 1:00pm | Melissa Schultz |
| Placebo Effects | Tuesday, March 19, 2013 – 12:00pm to 1:00pm | Allison Furey |
| Recent developments in Rheumatoid Arthritis | Wednesday, January 23, 2013 – 12:00pm to 1:00pm | Gabriel Nicholas |
| Major Depressive Disorder (in Children and Adolescence), Overview of the Pristiq Phase III Pediatric Trials | Wednesday, December 5, 2012 – 12:00pm to 1:00pm | Scott Diegel |
Additional Information
Jeanne McCabe
Clinical Trials Program Manager
mccabe@biostat.wisc.edu
608-265-6702